Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Diagnosing pulmonary tuberculosis using sequence-specific purification of urine cell-free DNA

View ORCID ProfileAmy Oreskovic, Nuttada Panpradist, Diana Marangu, M. William Ngwane, Zanele P. Magcaba, Sindiswa Ngcobo, Zinhle Ngcobo, David J. Horne, Douglas P.K. Wilson, Adrienne E. Shapiro, Paul K. Drain, Barry R. Lutz
doi: https://doi.org/10.1101/2021.01.19.21249296
Amy Oreskovic
aDepartment of Bioengineering, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amy Oreskovic
Nuttada Panpradist
aDepartment of Bioengineering, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Marangu
bDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. William Ngwane
cUmkhuseli Innovation and Research Management, Pietermaritzburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zanele P. Magcaba
cUmkhuseli Innovation and Research Management, Pietermaritzburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sindiswa Ngcobo
cUmkhuseli Innovation and Research Management, Pietermaritzburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zinhle Ngcobo
cUmkhuseli Innovation and Research Management, Pietermaritzburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Horne
dDepartment of Medicine, University of Washington, Seattle, WA, USA
eDepartment of Global Health, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas P.K. Wilson
cUmkhuseli Innovation and Research Management, Pietermaritzburg, South Africa
fEdendale Hospital, University of KwaZulu-Natal, Pietermaritzburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne E. Shapiro
dDepartment of Medicine, University of Washington, Seattle, WA, USA
eDepartment of Global Health, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul K. Drain
dDepartment of Medicine, University of Washington, Seattle, WA, USA
eDepartment of Global Health, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: blutz@uw.edu pkdrain@uw.edu
Barry R. Lutz
aDepartment of Bioengineering, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: blutz@uw.edu pkdrain@uw.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Transrenal urine cell-free DNA (cfDNA) is a promising tuberculosis (TB) biomarker, but is challenging to detect because of the short length (<100 bp) and low concentration of TB-specific fragments. We aimed to improve the diagnostic sensitivity of TB urine cfDNA by increasing recovery of short fragments during sample preparation. We developed a highly sensitive sequence-specific purification method that uses hybridization probes immobilized on magnetic beads to capture short TB cfDNA (50 bp) with 91.8% average efficiency. Combined with short-target PCR, the assay limit of detection was ≤5 copies of cfDNA in 10 mL urine. In a clinical cohort study in South Africa, our urine cfDNA assay had 83.7% sensitivity (95% CI: 71.0– 91.5%) and 100% specificity (95% CI: 86.2–100%) for diagnosis of active pulmonary TB when using sputum Xpert MTB/RIF as the reference standard. The detected cfDNA concentration was 0.14–2804 copies/mL (median 14.6 copies/mL) and was inversely correlated with CD4 count and days to culture positivity. Sensitivity was non-significantly higher in HIV-positive (88.2%) compared to HIV-negative patients (73.3%), and was not dependent on CD4 count. Sensitivity remained high in sputum smear-negative (76.0%) and urine LAM-negative (76.5%) patients. With improved sample preparation, urine cfDNA is a viable biomarker for TB diagnosis. Our assay has the highest reported accuracy of any TB urine cfDNA test to date and has the potential to enable rapid non-sputum-based TB diagnosis across key underserved patient populations.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

http://dx.doi.org/10.17504/protocols.io.bep4jdqw

Funding Statement

Research reported in this publication was funded by the Bill and Melinda Gates Foundation under award number OPP1152864 and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R21AI125975. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was funded in part by a 2018 CFAR developmental grant from the University of Washington/Fred Hutch Center for AIDS Research, an NIH-funded program under award number AI027757 which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK. A.O. was supported by funding from the National Science Foundation Graduate Research Fellowship Program.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The research described was approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee (#BE475/18) and the University of Washington Institutional Review Board (#48840).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • These authors share senior authorship.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Diagnosing pulmonary tuberculosis using sequence-specific purification of urine cell-free DNA
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Diagnosing pulmonary tuberculosis using sequence-specific purification of urine cell-free DNA
Amy Oreskovic, Nuttada Panpradist, Diana Marangu, M. William Ngwane, Zanele P. Magcaba, Sindiswa Ngcobo, Zinhle Ngcobo, David J. Horne, Douglas P.K. Wilson, Adrienne E. Shapiro, Paul K. Drain, Barry R. Lutz
medRxiv 2021.01.19.21249296; doi: https://doi.org/10.1101/2021.01.19.21249296
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Diagnosing pulmonary tuberculosis using sequence-specific purification of urine cell-free DNA
Amy Oreskovic, Nuttada Panpradist, Diana Marangu, M. William Ngwane, Zanele P. Magcaba, Sindiswa Ngcobo, Zinhle Ngcobo, David J. Horne, Douglas P.K. Wilson, Adrienne E. Shapiro, Paul K. Drain, Barry R. Lutz
medRxiv 2021.01.19.21249296; doi: https://doi.org/10.1101/2021.01.19.21249296

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (198)
  • Anesthesia (54)
  • Cardiovascular Medicine (492)
  • Dentistry and Oral Medicine (90)
  • Dermatology (57)
  • Emergency Medicine (169)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (213)
  • Epidemiology (5714)
  • Forensic Medicine (3)
  • Gastroenterology (217)
  • Genetic and Genomic Medicine (871)
  • Geriatric Medicine (88)
  • Health Economics (232)
  • Health Informatics (765)
  • Health Policy (395)
  • Health Systems and Quality Improvement (254)
  • Hematology (105)
  • HIV/AIDS (184)
  • Infectious Diseases (except HIV/AIDS) (6511)
  • Intensive Care and Critical Care Medicine (393)
  • Medical Education (118)
  • Medical Ethics (28)
  • Nephrology (93)
  • Neurology (851)
  • Nursing (44)
  • Nutrition (142)
  • Obstetrics and Gynecology (163)
  • Occupational and Environmental Health (263)
  • Oncology (515)
  • Ophthalmology (164)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (251)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (976)
  • Public and Global Health (2241)
  • Radiology and Imaging (377)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (313)
  • Rheumatology (109)
  • Sexual and Reproductive Health (81)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)